Abstract
IgA nephropathy was first described by Berger and Hinglais (1) in 1968, and has been referred to as Berger’s disease. The term IgA nephropathy in this chapter is limited to primary IgA nephropathy because mesangial deposits of IgA are observed in various other diseases (2). IgA nephropathy is known to be one of the most common types of primary glomerulonephritis in many parts of the world, and its prognosis is not so benign as was initially thought (3). The most urgent requirement in the study of IgA nephropathy is to determine its pathogenesis and treatment. The aim of this chapter is to summarize recent advances in the knowledge of these aspects of this disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Berger, J. and Hinglais, N.: Les Depots intercapillaires d’IgA-IgG. J. Urol. (Paris) 74:694–695, 1968.
Clarkson, A.R.: IgA nephropathy: history, classification and geographic distribution. In: IgA Nephropathy (Ed. A.R. Clarkson), Martinus Nijhoff Publishing, Boston, Dordrecht and Lancaster, 1987, pp. 1–8.
D’Amico, G.: Idiopathic IgA mesangial nephropathy. Nephron 41:1–13, 1985.
Berger, J.: IgA glomerular deposits in renal disease. Transplant. Proc. 1:939–944, 1969.
Lamperi, S. and Carozzi, S.: Skin-muscle biopsy in patients with various nephropathies. Nephron 24:46–50, 1979.
Hall, R.P., Stachura, I., Cason, J., Whiteside, T.L. and Lawley, T.J.: IgA-containing circulating immune complexes in patients with IgA nephropathy. Am. J. Med. 74:56–63, 1983.
Berger, J., Yaneva, H., Nabarra, B. and Barbanel, C.: Recurrence of mesangial deposition after renal transplantation. Kidney Int. 7:232–241, 1975.
Sanfilippo, F., Croker, B.P. and Bollinger, R.B.: Fate of four cadaveric donor renal allografts with mesangial IgA deposits. Transplantation 33:370–376, 1982.
Sakai, H.: Lymphocyte function in IgA nephropathy. In: IgA Nephropathy (Ed. A.R. Clarkson), Martinus Nijhoff Publishing, Boston, Dordrecht and Lancaster, 1987, pp. 176–187.
Egido, J., Julian, B.A. and Wyatt, R.J.: Genetic factors in primary IgA nephropathy. Nephrol. Dial. Transplant. 2:134–142, 1987.
Bene, M-C. and Faure, G.: Berger’s disease: Recent advances in immunology and genetics. Adv. Nephrol. 16:281–290, 1987.
Conley, M.E., Cooper, M.D. and Michael, A.F.: Selective deposition of IgA1 in IgA nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J. Clin. Invest. 66:1432–1436, 1980.
Tomino, Y., Endoh, M., Nomoto, Y. and Sakai, H.: Immunoglobulin A1 in IgA nepdhropathy. N. Eng. J. Med. 305:1159–1160, 1981.
Valentijn, R.M., Radl, J., Haaijman, J.J., Vermeer, B.J., Weening, J.J., Kauffmann, R.H., Daha, M.R. and van Es, L.A.: Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy. Kidney Int. 26:760–766, 1984.
Andre, C., Berthoux, F.C., Andre, F., Gillon, J., Genin, C. and Sabatier, J-C.: Prevalence of IgA2 deposits in IgA nephropathies. N. Eng. J. Med. 303:1343–1346, 1980.
Crago, S.S., Kutteh, W.H., Moro, I., Allansmith, M.R., Radl, J., Haaijman, J.J. and Mestecky, J.: Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues. J. Immunol. 132:16–18, 1984.
Lai, K-N., Chan, K.W., Lai, F.M-C., Ho, C.P., Yan, K.W., Lam, C.W.K. and Vallance-Owen, J.: The immunochemical characterization of the light chains in the mesangial IgA deposits in IgA nephropathy. Am. J. Clin. Pathol. 85:548–551, 1986.
Trascasa, M.L., Egido, J., Sancho, J. and Hernando, L.: IgA glomerulonephritis (Berger’s disease): Evidence of high serum levels of polymeric IgA. Clin. Exp. Immunol. 42:247–254, 1980.
Tomino, Y., Sakai, H., Miura, M., Endoh, M. and Nomoto, Y.: Detection of polymeric IgA in gloermuli from patients with IgA nephropathy. Clin. Exp. Immunol. 49:419–425, 1982.
Komatsu, N., Nagura, H., Watanabe, K., Nomoto, Y. and Kobayashi, K.: Mesangial deposits of J-chain linked polymeric IgA nephropathy. Nephron 33:61–64, 1983.
Bene, M-C., Faure, G. and Duheille, J.: IgA nephropathy: Characterization of the polymeric nature of mesangial deposits by in vitro binding of free secretory component. Clin. Exp. Immunol. 47:527–534, 1982.
Kutteh, W., Prince, S.J. and Mestecky, J.: Tissue origins of human polymeric and monomeric IgA. J. Immunol. 128:990–995, 1982.
Monteiro, R.C., Halbwachs-Mecarelli, L., Roque-Barreira, M.C., Noel, L-H., Berger, J. and Lesavre, P.: Charge and size of mesangial IgA in IgA nephropathy. Kidney Int. 28:666–671, 1985.
Monteiro, R.C., Chevailler, A., Noel, L.H. and Lesavre, P.: Negatively-charged serum IgA detected by in vitro binding to cationic proteins in patients with IgA nephropathy. In: Proceedings of the Xth International Congress of Nephrology (Ed. J.S. Cameron), 1987, p. 394.
Tomino, Y., Endoh, M., Nomoto, Y. and Sakai, H.: Specificity of IgA antibody in IgA nephropathy. Nephron 29:103–104, 1981.
Tomino, Y., Sakai, H., Endoh, M., Miura, M., Suga, T., Kaneshige, H. and Nomoto, Y.: Cross reactivity of eluted antibodies from renal tissues of patients with Henoch-Schoenlein purpura and IgA nephropathy. Am. J. Nephrol. 3:315–318, 1983.
Tomino, Y., Sakai, H., Endoh, M., Suga, T., Miura, M., Kaneshige, H. and Nomoto, Y.: Cross reactivity of IgA antibodies between renal mesangial areas and nuclei of tonsillar cells in patients with IgA nephropathy. Clin. Exp. Immunol. 51:605–611, 1983.
Tomino, Y., Sakai, H., Miura, M., Endoh, M., Suga, T. and Nomoto, Y.: Detection of antigenic substances in patients with IgA nephropathy. Contrib. Nephrol. 40:69–73, 1984.
Tomino, Y., Sakai, H., Miura, M., Suga, T., Endoh, M., Nomoto, Y., Umehara, K. and Hashimoto, K.: Specific binding of circulating IgA antibodies in patients with IgA nephropathy. Am. J. Kid. Dis. 3:149–153, 1985.
Nagy, J., Uj, M., Szucs, G., Trinn, Cs. and Burger, T.: Herpes virus antigens and antibodies in kidney biopsies and sera of IgA glomerulonephritis. Clin. Nephrol. 21:259–262, 1984.
Russell, M.W., Mestecky, J., Julian, B.A. and Galla, J.H.: IgA-associated renal diseases: Antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli J. Clin. Immunol. 6:74–86, 1986.
Tomino, Y., Yagame, M., Omata, F., Nomoto, Y. and Sakai, H.: A case of IgA nephropathy associated with adeno and herpes simplex virus. Nephron, 47:258–261, 1987.
McCoy, R.C., Abramowsky, C.R. and Tisher, C.C.: IgA nephropathy. Am. J. Pathol. 76:123–144, 1974.
Evans, D.J., Williams, D.G., Peters, D.K., Sissons, J.G.P., Boulton-Jones, J.M., Ogg, C.S., Cameron, J.S. and Hoffbrand, B.I.: Glomerular deposition of properdin in Henoch-Schoenlein syndrome and idiopathic focal nephritis. Br. Med. J. iii:326–328, 1973.
Rauterberg, E.W., Lieberknecht, H-M., Wingen, A-M. and Ritz, E.: Complement membrane attack (MAC) in idiopathic IgA-gloemrulonephritis. Kidney Int. 31:820–829, 1987.
Tomino, Y., Endoh, M., Nomoto, Y. and Sakai, H.: Activation of complement by renal tissues from patients with IgA nephropathy. J. Clin. Pathol. 34:35–40, 1981.
Wyatt, R.J., Kanayama, Y., Julian, B.A., Negoro, N., Sugimoto, S., Hudson, E.C. and Curd, J.G.: Complement activation in IgA nephropathy. Kidney Int. 31:1019–1023, 1987.
McLean, R.H., Wyatt, R.J. and Julian, B.A.: Complement phenotypes in glomerulonephritis: Increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch-Schonlein purpura. Kidney Int. 26:855–860, 1984.
Wyatt, R.J., Julian, B.A., Galla, J.H. and McLean, R.: Increased frequency of C3 fast alleles in IgA nephropathy. Disease Marker 2:419–428, 1984.
Tomino, Y., Miura, M., Suga, T., Endoh, M., Nomoto, Y. and Sakai, H.: Detection of IgA1-dominant immune complexes in peripheral blood mononuclear leukocytes by double immunofluorescence in patients with IgA nephropathy. Nephron 37:137–139, 1984.
Sato, M., Kinugasa, E., Ideura, T. and Koshikawa, S.: Phagocytic activity of polymorphonuclear leukocyte in patients with IgA nephropathy. Clin. Nephrol. 19:166–171, 1983.
Roccatello, D., Coppo, R., Piccoli, G., Cordonnier, D., Martina, G., Rollino, C., Picciotto, G., Sena, L.M. and Amoroso, A.: Fc receptors blocking factors in IgA nephropathies. Clin. Nephrol. 23:159–168, 1985.
Lawrence, S., Pussell, B.A. and Charlesworth, J.A.: Mesangial IgA nephropathy: detection of defective reticulophagocytic function in vivo. Clin. Nephrol. 19:280–283, 1983.
Ooi, Y.M. and Ooi, B.S.: Identification of a monocyte phogocytic defect in a subpopulation of patients with nephritis. Kidney Int. 23:851–854, 1983.
Roccatello, D., Coppo, R., Basolo, B., Cordonnier, D., Picciotto, G., Sena, M. and Piccoli, G.: Interaction between macrophage system and IgA immune complexes in IgA nephropathy. Kidney Int. 24:423–424, 1983.
Roccatello, D., Coppo, R. and Piccoli, G.: Monocyte macrophage system function in primary IgA nephropathy. Contrib. Nephrol. 40:130–136, 1984.
Bannister, K.M., Hay, J., Clarkson, A.R. and Woodroffe, A.J.: Fc specific reticulo-endothelial clearance in SLE and glomerulonephritis. Am. J. Kidney Dis. 3:287–292, 1984.
D’Amico, G., Imbasciati, E., di Belgioioso, G.B., Bertoli, S., Fogazzi, G., Ferrario, F., Fellin, G., Ragni, A., Colasanti, G., Minetti, L. and Pomticelli, C.: Idiopathic IgA mesangial nephropathy. Medicine 64:49–60, 1985.
Sakai, H.: Immune system abnormalities in IgA nephropathy especially T-cell functions. Plasma Ther. Transfus. Technol 6:677–686, 1985.
Endoh, M., Suga, T. and Sakai, H.: IgG, IgA and IgM rheumatoid factors in patients with glomerulonephritis. Nephron 39:330–335, 1985.
Sinico, R.A., Fornasieri, A., Oreni, N., Benuzzi, S. and D’Amico, D.: Polymeric IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger’s disease). J. Immunol. 137:536–541, 1986.
Nomoto, Y., Miura, M., Suga, T., Endoh, M., Tomino, Y. and Sakai, H.: Cold reacting anti-nuclear factor (ANF) in families of patients with IgA nephropathy. Clin. Exp. Immunol. 58:63–67, 1984.
Nomoto, Y., Suga, T., Miura, M., Nomoto, H., Tomino, Y. and Sakai, H.: Characterization of an acidic nuclear protein recognized by autoantibodies in sera from patients with IgA nepdhropathy. Clin. Exp. Immunol. 65:513–519, 1986.
Cederholm, B., Wieslander, J., Bygren, P. and Heinegard, D.: Patients with IgA nephropathy have circulating anti-basement membrane antibodies reacting with structures common to collagen I, II, and IV. Proc. Natl. Acad. Sci. USA 83:6151–6155, 1986.
Endoh, M., Suga, T., Miura, M., Tomino, Y., Nomoto, Y. and Sakai, H.: In vivo alteration of antibody production in patients with IgA nephropathy. Clin. Exp. Immunol. 57:564–570, 1984.
Coppo, R., Basolo, B., Rollino, C., Roccatello, D., Martina, G., Amore, A., Bongiorno, G. and Piccoli, G.: Mediterranean diet and primary IgA nephropathy. Clin. Nephrol. 26:72–82, 1986.
Sato, M., Takayama, K., Wakasa, M. and Koshikawa, S.: Estimation of circulating immune complexes following oral challenge with cow’s milk in patients with IgA nephropathy. Nephron 47:43–48, 1987.
Sakai, H., Nomoto, Y., Tomino, Y., Endoh, M., Miura, M. and Suga, T.: Increases of in vitro and in vivo production of polyclonal IgA in patients and their family members with IgA nephropathy. In: Recent Advances in Mucosal Immunology, Part B (Eds. J.R. McGhee, J. Mestecky, P.L. Ogra and J. Bienenstock), Plenum Press, New York and London, 1987, pp. 1507–1514.
Lesavre, P.H., Digeon, M. and Bach, J.F.: Analysis of circulating IgA and detection of immune complexes in primary IgA nephropathy. Clin. Exp. Immunol. 48:61–69, 1982.
Yagame, M., Tomino, Y., Miura, M., Tanigaki, T., Suga, T., Nomoto, Y. and Sakai, H.: Detection of IgA-class circulating immune complexes (CIC) in sera from patients with IgA nephropathy using a solid-phase anti-C3 Facb enzyme immunoassay (EIA). Clin. Exp. Immunol. 67:270–276, 1987.
Yap, H.K., Sakai, R.S., Woo, K.T., Lim, C.H. and Jordan, S.C.: Detection of bovine serum albumin in the circulating IgA immune complexes of patients with IgA nephropathy. Clin. Immunol. Immunopathol. 43:395–402, 1987.
Nomoto, Y., Sakai, H. and Arimori, S.: Increase of IgA-bearing lymphocytes in peripheral blood from patients with IgA nephropathy. Am. J. Clin. Pathol. 71:158–160, 1979.
Sakai, H., Nomoto, Y., Arimori, S., Komori, K., Inouye, H. and Tsuji, K.: Increase of IgA-bearing peripheral blood lymphocytes in families of patients with IgA nephropathy. Am. J. Clin. Pathol. 72:452–456, 1979.
Cosio, F.G., Lam, S., Folami, A.O., Conley, M.E. and Michael, A.F.: Immune regulation of immunoglobulin production in IgA nephropathy. Clin. Immunol. Immunopathol. 23:430–436, 1982.
Fiorini, G., Fornasier, A., Sinico, R., Colasanti, G., Gibelli, A., Corneo, R. and D’Amico, G.: Lymphocyte populations in the peripheral blood from patients with IgA nephropathy. Nephron 31:354–357, 1982.
Feehally, J., Beattie, T.J., Brenchley, P.E.C., Coupes, B.M., Mallick, N.P. and Postlethwaite, R.J.: Sequential study of the IgA system in relapsing IgA nephropathy. Kidney Int. 29:924–931, 1986.
Garcia-Hoyo, R., Lozano, L. and Egigo, J.: Immune abnormalities of IgA in six families with IgA nephropathy. In: Recent Advances in Mucosal Immunology, Part B (Eds. J.R. McGhee, J. Mestecky, P.L. Ogra and J. Beinenstock), Plenum Press, New York and London, 1987, pp. 1499–1505.
Bene, M-C., Faure, G., de Ligney, B.H., Kessler, M. and Duheille, J.: IgA nephropathy: Quantitative immunohistomorphometry of the tonsillar plasma cells evidences an inversion of the IgA versus IgG secreting cell membrane. J. Clin. Invest. 71:1342–1347, 1983.
Egido, J., Blasco, R., Lozano, L., Sancho, J. and Garcia-Hoyo, R.: Immunological abnormalities in tonsils of patients with IgA nephropathy: inversion in the percentage of IgA versus IgG-bearing lymphocytes and increased polymeric IgA synthesis. Clin. Exp. Immunol. 57:101–106, 1984.
Egido, J., Blasco, R., Sancho, J., Lozano, L., Sanchez-Crespo, M. and Hernando, L.: Increased rates of polymeric IgA synthesis by circulating lymphoid cells in IgA mesangial glomerulonephritis. Clin. Exp.Immunol. 47:309–316, 1982.
Hale, G.M., Mcintosh, S.L., Hiki, Y., Clarkson, A.R. and Woodroffe, A.J.: Evidence for IgA-specific B cell hyperactivity in patients with IgA nephropathy. Kidney Int. 29:718–724, 1986.
Waldo, F.B., Beischel, L. and West, C.D..: IgA synthesis by lymphocytes from patients with IgA nephropathy and their relatives. Kidney Int. 29:1229–1233, 1986.
Elson, C.O.: T cell specific IgA switching and for IgA B-cell differentiation. Immunology Today 4:189–190, 1983.
Sakai, H., Nomoto, Y. and Arimori, S.: Decrease of IgA-specific suppressor T cell activity in patients with IgA nephropathy. Clin. Exp. Immunol. 38:243–248, 1979.
Egido, J., Blasco, R.A., Sancho, J. and Hernando,: Immunological abnormalities in healthy relatives of patients with IgA nephropathy. Am. J. Nephrol. 5:14–20, 1985.
Chatenoud, L. and Bach, M-A.: Abnormalities of T-cell subsets in glomerulonephritis and systemic lupus erythematosus. Kidney Int. 20:267–274, 1981.
Egido, J., Blasco, R., Sancho, J. and Lozano, L.: T-cell dysfunction in IgA nephropathy: Specific abnormalities in the regulation of IgA synthesis. Clin. Immunol. Immnopathol. 26:201–212, 1983.
Rothschild, E. and Chatenoud, L.: T cell subset modulation of immunoglobulin production in IgA nephropathy and membranous glomerulonephritis. Kidney Int. 25:557–564, 1984.
Cagnoli, L., Beltrandi, E., Pasquali, S., Biagi, R., Casadei-Maldini, M., Rossi, L. and Zucchelli, P.: B and T cell abnormalities in patients with primary IgA nephropathy. Kidney Int. 28:646–651, 1985.
Endoh, M., Sakai, H., Nomoto, Y., Tomino, Y. and Kaneshige, H.: IgA-specific helper activity of Tα cells in human peripheral blood. J. Immunol. 127:2612–2613, 1981.
Sakai, H., Endoh, M., Tomino, Y. and Nomoto, Y.: Increase of IgA specific helper Tα cells in patients with IgA nephropathy. Clin. Exp. Immunol. 50:77–82, 1982.
Suga, T., Endoh, M., Sakai, H., Miura, M., Tomino, Y. and Nomoto, Y.: Tα cell subsets in human peripheral blood. J. Immunol. 134:1327–1329, 1985.
Sakai, H., Yasumoto, Y., Suga, T., Endoh, M., Tomino, Y. and Nomoto, Y.: Increase of IgA-specific switch T cells in patients with IgA nephropathy. In: Proceedings of the Xth International Congress of Nephrology (Ed. J.S. Cameron), London, 1987, p. 402.
Kawanishi, H., Saltzman, L.E. and Strober, W.: Mechanisms regulating IgA class-specific immunoglobulin production in murine gut-associated lymphoid tissues. 1. T cells derived from Peyer’s patches that switch sIgM B cells to sIgA B cells in vitro. J. Exp. Med. 157:433–450, 1983.
Yodoi, J., Adachi, M. and Noro, N.: IgA binding factors and Fc receptors for IgA: Comparative studies between IgA and IgE Fc receptor system. Int. Rev. Immunol. 2:117–141, 1987.
Harriman, G.R. and Strober, W.: Interleukin 5, a mucosal lymphokine? J. Immunol. 139:3553–3555, 1987.
Power, D.A., Muirhead, N., Simpson, J.G., Nicholls, A.J., Horne, C.H.W., Gotto, G.R.D. and Edward, N.: IgA nephropathy is not a rare disease in the United Kingdom. Nephron 40:180–184, 1985.
Jennette, J.C., Wall, S.D. and Wilkman, A.S., Kideny Int.: Low incidence of IgA nephropathy in blacks. 28:944–950, 1985.
Julian, B.A., Quiggins, P.A., Thompson, J.S., Woodford, S.Y., Gleason, K. and Wyatt, R.J.: Familial IgA nephropathy. Evidence for an inherited mechanism of disease. N. Eng. J. Med. 312:202–208, 1985.
Wyatt, R.J., Rivas, M.L., Julian, B.A., Quiggins, P.A., Woodford, S.Y., McMorrow, R.G. and Beahler, R.W.: Regionalization in hereditary IgA nephropathy. Am. J. Hum. Genet. 41:36–50, 1987.
Julian, B.A., Phillips, J.A.III., Orlando, P.J., Wyatt, R.J. and Butler, M.G.: Analysis of immunoglobulin heavy chain restriction fragment length polymorphisms in IgA nephropathy. Seminar in Nephrol. 7:306–310, 1987.
Rambausek, M., Knight, J.F., Williams, D.G., Welsh, K.I., Ritz, E. and Demaine, A.G.: Relation of mesangial IgA-GN to polymorphism of immunoglobulin heavy chain switch region. In: Proceedings of the Xth International Congress of Nephrology (Ed. J.S. Cameron), London, 1987, p. 400.
Davin, J.D., Malaise, M., Foidart, J.B. and Mahieu, P.: Evidence that carbohydrates of the Fc domain of IgA are involved in the formation of large IgA-immune complexes in IgA-associated nephropathies. In: Proceedings of the Xth International Congress of Nephrology (Ed. J.S. Cameron), London, 1987, p. 322.
DeWerra, P., Morel-Marogeer, L., Leroux-Robert, C. and Richet, P.: Glomerulites a depots d’IgA diffus dans le mesangium. Schweiz. Med. Wochenschr. 761–768, 797–803, 1973.
Sissons, J.G., Woodrow, D.F., Curtis, J.G., Evans, D.J., Goover, P.E. and Slopper, J.G.: Isolated glomerulonephritis with mesangial IgA deposits. Br. Med. J. iii:611–614, 1975.
Tolkoff-Rubin, N.E., Cosimi, A.B., Fuller, T., Rubin, R.H. and Colvin, R.B.: IgA nephropathy in HLA-identical siblings. Transplantation 26:430–433, 1978.
Yoshikawa, T., Ito, H., Nakahara, C., Yoshihara, S., Yoshiya, K., Matsuo, T., Hasegawa, O., Hazikano, H. and Okada, S.: Glomerular electron-dense deposits in childhood IgA nephropathy. Virchows Arch. A. 406:33–43, 1985.
Hogg, R.J. and Silva, F.G.: IgA nephropathy in children. In: IgA Nephropathy (Ed. A.R. Clarkson), Martinus Nijhoff Publishing, Boston, Dordrecht and Lancaster, 1987, pp. 16–38.
Droz, D.: IgA nephropathy: clinicopathological correlations. In: IgA Nephropathy (Ed. A.R. Clarkson), Martinus Nijhoff Publishing, Boston, Dordrecht and Lancaster, 1987, pp. 97–107.
D’Amico, G., Minetti, L., Ponticelli, C., Fellin, G., Ferrario, F., Barbiano di Belgioioso, G., Imbasciati, E., Ragni, A., Bertoli, S., Fogazzi, G. and Duca, G.: Prognostic indicators in idiopathic IgA mesangial nephropathy. Quart. J. Med. New Series 59:363–378, 1986.
Tojo, S., Narita, M., Miyahara, T., Sakai, O., Ohno, J., Soeda, N., Honda, N., Nagase, M., Sibata, M., Orita, Y., Ishikawa, H., Hara, K. and Sakuma, A.: Manseisikyuutaijinen ni taisuru trimetazidine dihydrochloride no rinshokouka. Jin to Toseki 19:1367–1380, 1985.
Tojo, S., Honda, N., Sibata, M., Narita, M., Miyahara, T., Sakai, O., Katoh, E., Kida, H., Orita, Y., Ishikawa, H., Hara, K., Tanaka, T. and Takasaki, H.: Manseisikyuutaijinen ni tausuru AS-05 (Dilazep) no rinshouhyouka. Jin to Toseki 20:289–313, 1986.
Kobayashi, Y., Fujii, K., Hiki, Y. and Tateno, S.: Steroid therapy in IgA nephropathy: A prospective pilot study in moderate proteinuric cases. Quart. J. Med. New Series 61:935–943, 1986.
Laurent, J., Belghiti, D., Bruneau, C. and Lagrue, G.: Diclofenac, a nonsteroidal anti-inflammatory drug, decreases proteinuria in some glomerular diseases: A controlled study. Am. J. Nephrol. 7:198–202, 1987.
Hamazaki, T., Tateno, S. and Shishido, H.: Eicosa-pentaenoic acid and IgA nephropathy. Lancet i: 1017–1018, 1984.
Tomino, Y., Miura, M., Suga, T., Endoh, M., Nomoto, Y. and Sakai, H.: Defibrination of intraglomurular fibrin deposits by urokinase in patients with IgA nephropathy. Jpn. J. Nephrol. 26:275–280, 1984.
Miura, M., Tomino, Y., Yagame, M., Inoue, W., Suga, T., Nomoto, Y. and Sakai, H.: Significant correlation between the immunofluorescence of alpha 2-plasmin inhibitor in glomeruli and the effects of urokinase therapy in patients with IgA nephropathy. Annals Acad. Med. 15:255–257, 1986.
Tomino, Y., Sakai, H., Suga, T., Miura, M., Kaneshige, H., Endoh, M. and Nomoto, Y.: Impaired solubilization of glomerular immune deposits by sera from patients with IgA nephropathy. Am. J. Kidney Dis. 3:48–53, 1983.
Tomino, Y., Sakai, H., Woodroffe, A.J. and Clarkson, A.R.: Studies on glomerular immune solubilization by complement in patients with IgA nephropathy. Acta Pathol. Jpn. 37:1763–1767, 1987.
Tomino, Y., Sakai, H., Miura, M., Suga, T., Endoh, M. and Nomoto, Y.: Effect of danazol on solubilization of immune deposits in patients with IgA nephropathy. Am. J. Kidney Dis. 4:135–140, 1984.
Tomino, Y., Sakai, H., Hanzawa, S., Ohno, J., Kitajima, T. and Sakai, O.: Clinical effect of Danazol in patients with IgA nephropathy. Jpn. J. Med. 26:162–166, 1987.
Beukhof, H.R., ter Wee, P.M., Sluiter, W.J. and Donker, A.J.M.: Effect of low-dose dopamine on effective renal plasma flow and glomerular filtration rate in 32 patients with IgA nephropathy. Am. J. Nephrol. 5:267–270, 1985.
Lopez-Trascasca, M., Egido, J., Sancho, J. and Hernando, L.: Evidence of high polymeric IgA levels in serum of patients with Berger’s disease and its modification with phenytoin treatment. Proc. Eur. Dial. Transplant. Assoc. 16: 513, 1979.
Clarkson, A.R., Seymour, A.E., Woodroffe, A.J., McKenzie, P.E., Chan, Y-L. and Wootton, A.M.: Controlled trial of phenytoin therapy in IgA nephropathy. Clin. Nephrol. 13:215–218, 1980.
Coppo, R., Blasco, B., Bulzomi, M.R. and Piccoli, G.: Ineffectiveness of phenytoin treatment on IgA-containing circulating immune complexes in IgA nephropathy. Nephron 36:275–276, 1984.
Coppo, R., Basolo, B., Giachino, O., Rocatelli, D., Lajola, D., Mazzucco, G., Amore, A. and Picoli, G.: Plasmapheresis in a patient with rapidly progressive idiopathic IgA nephropathy: removal of IgA-containing immune complexes and clinical recovery. Nephron 40:488–490, 1985.
Clarkson, A.R.: The treatment of IgA nephropathy. In: IgA Nephropathy (Ed. A.R. Clarkson), Martinus Nijhoff Publishing, Boston, Dordrecht and Lancaster, 1987, p. 219.
Cameron, J.S. and Turner, D.R.: Recurrent glomerulonephritis in allografted kidneys. Clin. Nephrol. 7:47–51, 1977.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Sakai, H. (1989). IgA Nephropathy: Current Views on Pathogenesis and Treatment. In: Andreucci, V.E., Fine, L.G., Hatano, M., Kjellstrand, C.M. (eds) International Yearbook of Nephrology 1989. International Yearbooks of Nephrology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1673-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1673-2_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8934-0
Online ISBN: 978-1-4613-1673-2
eBook Packages: Springer Book Archive